High Science® – A New Partnership

Stephen Dailey Event Info Leave a Comment

For decades, the cannabis industry has struggled to erase a deep-rooted stigma, punctuated by various anti-cannabis propaganda campaigns, most notably by films, such as Reefer Madness. The complex science, innovative research, and health benefits of this plant are often over-shadowed by false narratives driven by fear, politics, and competing industry profits. It’s time for that narrative to change.  We are …

CannMed 2020 Registration Now Open!

Ben Amirault CannMed Features, Event Info Leave a Comment

It’s happening! 214 days until #CannMed2020! Join Medicinal Genomics and 60+ presenters in Pasadena, CA on September 20-22. Our 24,840 square foot exhibit hall will be filled with 50+ industry leading sponsors, exhibitors, and advocacy groups showcasing the greatest minds in cannabis science, medicine, cultivation, and safety. CannMed was born to promote understanding of cannabis’ complex science and its medical benefits …

Women’s Health and Cannabis: It’s Time to Put Our Money Where Our Health Is

Ben Amirault Event Info, Speaker Profiles Leave a Comment

We had a chance to catch up with Meredith Burak, Director of Global Relations for Asana Bio Group, who will lead a Women’s Health panel at CannMed 2018, comprised of experts who are advancing science and products to benefit women’s health. In the video below, Burak shares some of the information she has found while studying how cannabis can help …

Exploring the Convergence of Cannabis, Cryptocurrency, and Blockchain Technology

Ben Amirault Cryptocurrency, Event Info Leave a Comment

Our latest CannMed 2018 speaker interview is with Rob Viglione from Horizen who will be speaking as part of our Cryptocurrency Track at CannMed 2018. Cryptocurrencies and blockchains can radically disrupt many aspects of the cannabis market. Cryptocurrencies are now funding cannabis research projects, Cannabis scientific conferences, and ICO financing. The CannMed Crypto track will touch on ICO financing in the cannabis space, cryptocurrencies …

Identifying the Cannabis Compounds that Kill Cancer

Ben Amirault Event Info, Speaker Profiles Leave a Comment

In our latest CannMed 2018 speaker interview, David Meiri provides some amazing insight into how he and his team are working to understand the specific cannabis compounds that can be used to kill cancer cells. What they have found so far is fascinating. By testing different cannabis extracts on cancer cells with specific genetic mutations, they can identify which cannabis …

Dr. Dor Discusses the Challenges with Implementing Israel’s Medical Cannabis Program

Ben Amirault Event Info, Speaker Profiles Leave a Comment

We had a chance to speak with Dr. Michael Dor, Chief Medical Consultant in the Israeli Health Ministry Medical Cannabis Unit, about the challenges he has faced implementing the country’s medical cannabis program. In the video below, Dr. Dor says physicians in Israel are resistant to prescribing cannabis, but it’s not because there is not enough medical evidence. It’s just …

Dr. Mechoulam Discusses Research into Addiction

Ben Amirault Event Info, Speaker Profiles Leave a Comment

We are so fortunate to have Dr. Raphael Mechoulam on our CannMed 2018 Advisory Board. His early contributions to cannabis research are the foundation that today’s cannabis researchers and healthcare providers use to advance the understanding this amazing plant’s medical efficacy. We had the chance to speak with Dr. Mechoulam at his laboratory in Israel about his pioneering cannabis research …

Former NFL Players Lead Panel Discussion on Medical Cannabis Use in Professional Sports

KyAnn Anderson-McKernan CannMed Features, Event Info, Slider, Speaker Profiles Leave a Comment

Former NFL players, Nate Jackson, Ricky Williams, Eben Britton, and Lance Johnstone will be joined by Dr. David Nathan, Dr. Perry Solomon, and moderator Jim McAlpine for a special panel discussion about medical cannabis as a viable alternative to often addictive opiates. According to an ESPN poll released in November 2016, 61% of NFL players believed painkiller use would decrease if the …